These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anti-angiogenic gene therapy for cancer (review). Isayeva T; Kumar S; Ponnazhagan S Int J Oncol; 2004 Aug; 25(2):335-43. PubMed ID: 15254730 [TBL] [Abstract][Full Text] [Related]
3. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis. Dorer DE; Nettelbeck DM Adv Drug Deliv Rev; 2009 Jul; 61(7-8):554-71. PubMed ID: 19394376 [TBL] [Abstract][Full Text] [Related]
4. Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents (review). Bauerschmitz GJ; Barker SD; Hemminki A Int J Oncol; 2002 Dec; 21(6):1161-74. PubMed ID: 12429964 [TBL] [Abstract][Full Text] [Related]
5. Intraarterial delivery of genetic vectors for the treatment of malignant brain tumors. Cohen ZR; Duvdevani R; Nass D; Hadani M; Ram Z Isr Med Assoc J; 2001 Feb; 3(2):117-20. PubMed ID: 11344821 [TBL] [Abstract][Full Text] [Related]
6. Parvovirus vectors: use and optimisation in cancer gene therapy. Blechacz B; Russell SJ Expert Rev Mol Med; 2004 Jul; 6(16):1-24. PubMed ID: 15387896 [TBL] [Abstract][Full Text] [Related]
7. Tumor endothelial cells are targets for selective therapies: in vitro and in vivo models to evaluate antiangiogenic strategies. Dutour A; Rigaud M Anticancer Res; 2005; 25(6B):3799-807. PubMed ID: 16309166 [TBL] [Abstract][Full Text] [Related]
8. Viral gene therapy strategies: from basic science to clinical application. Young LS; Searle PF; Onion D; Mautner V J Pathol; 2006 Jan; 208(2):299-318. PubMed ID: 16362990 [TBL] [Abstract][Full Text] [Related]
9. Targeting strategies in cancer gene therapy. Wang JH; Liu XY Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):311-6. PubMed ID: 12673383 [TBL] [Abstract][Full Text] [Related]
10. Delivery of viral vectors to tumor cells: extracellular transport, systemic distribution, and strategies for improvement. Wang Y; Yuan F Ann Biomed Eng; 2006 Jan; 34(1):114-27. PubMed ID: 16520902 [TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy. Hu YL; Fu YH; Tabata Y; Gao JQ J Control Release; 2010 Oct; 147(2):154-62. PubMed ID: 20493219 [TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenic strategies for cancer therapy (Review). Benouchan M; Colombo BM Int J Oncol; 2005 Aug; 27(2):563-71. PubMed ID: 16010440 [TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic gene therapy of cancer: current status and future prospects. Persano L; Crescenzi M; Indraccolo S Mol Aspects Med; 2007 Feb; 28(1):87-114. PubMed ID: 17306361 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy. Gardlik R; Behuliak M; Palffy R; Celec P; Li CJ Gene Ther; 2011 May; 18(5):425-31. PubMed ID: 21228886 [TBL] [Abstract][Full Text] [Related]
16. On the strategy of using nonviral carriers in cancer gene therapy. Sochanik A; Szala S Acta Biochim Pol; 1996; 43(2):293-300. PubMed ID: 8862173 [TBL] [Abstract][Full Text] [Related]
17. Targeting of therapeutics to the liver: liposomes and viral vectors. Di Campli C; Wu J; Zern MA Alcohol Clin Exp Res; 1999 May; 23(5):950-4. PubMed ID: 10371421 [TBL] [Abstract][Full Text] [Related]
18. From gene therapy to virotherapy for ovarian cancer. Stoff-Khalili MA; Dall P; Curiel DT Minerva Ginecol; 2004 Dec; 56(6):503-14. PubMed ID: 15729203 [TBL] [Abstract][Full Text] [Related]
19. Latest development in viral vectors for gene therapy. Lundstrom K Trends Biotechnol; 2003 Mar; 21(3):117-22. PubMed ID: 12628368 [TBL] [Abstract][Full Text] [Related]